- Report
- December 2024
- 1214 Pages
Global
From €1449EUR$1,648USD£1,200GBP
- Report
- October 2024
- 194 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 184 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- October 2024
- 194 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- April 2025
- 93 Pages
Global
From €5324EUR$5,850USD£4,564GBP
- Report
- February 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 175 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- April 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 200 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- March 2025
- 250 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- July 2024
Global
From €4414EUR$4,850USD£3,784GBP
- Report
- April 2025
- 250 Pages
Global
From €4086EUR$4,490USD£3,503GBP
- Report
- September 2024
- 136 Pages
Global
From €2729EUR$2,999USD£2,340GBP
- Report
- August 2024
- 200 Pages
Global
From €3521EUR$3,869USD£3,019GBP
- Report
- August 2021
- 180 Pages
Global
From €1182EUR$1,299USD£1,014GBP
- Report
- December 2022
- 409 Pages
Global
From €1207EUR$1,373USD£1,000GBP
- Report
- January 2023
- 242 Pages
Global
From €1207EUR$1,373USD£1,000GBP
- Report
- February 2024
- 237 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- March 2023
- 935 Pages
Global
€1449EUR$1,648USD£1,200GBP
- Report
- June 2022
- 553 Pages
Global
From €1207EUR$1,373USD£1,000GBP

Wearable drug delivery devices, as a subset within the medical devices sector, encompass a range of products designed to administer medications directly to patients without the need for traditional, more invasive methods of drug administration. These devices offer continuous, controlled drug delivery, often through the skin. The market for these devices includes various technologies such as transdermal patches, insulin pumps, and other wearable injectors, catering to a range of chronic diseases, including diabetes, cardiovascular diseases, and autoimmune disorders.
Users generally appreciate these devices for their convenience, discretion, and the capability to maintain a consistent level of medication in the bloodstream, which can be particularly advantageous for the management of chronic conditions. The advances in material sciences, microelectronics, and biotechnology have been crucial in the development and improvement of these devices, offering better patient compliance and enhanced therapeutic effectiveness.
In terms of companies in the market, there are several notable entities. Insulet Corporation is known for its innovative insulin delivery systems. Medtronic offers a comprehensive range of medical devices, including wearable drug delivery solutions. Tandem Diabetes Care specializes in insulin pumps, and Dexcom develops continuous glucose monitoring systems that can integrate with wearable insulin delivery devices. Additionally, pharmaceutical giant Johnson & Johnson operates in various healthcare sectors, including the development of wearable drug delivery solutions through its subsidiary companies. Show Less Read more